Evidence map›Paper›PMID 41225091›Full record

ReviewAdvances in experimental medicine and biology2026

Oral Innate Immunity and the Role of Oral Epithelial Cells.

Wipawee Nittayananta

Abstract readReview
PubMed Publisher
In one paragraph

Review in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Wipawee NittayanantaFaculty of Dentistry, Bangkokthonburi University, Bangkok, Thailand. wipawee.nit@bkkthon.ac.th.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The oral mucosal epithelium is a complex structure that protects the underlying tissues from environmental exposure. Epithelial cells lining the mucosal surfaces of the oral cavity play an important role in innate immunity. They consist of stratified squamous epithelia that not only serve as a physical barrier but also contribute to innate immunity through the production of antimicrobial peptides and cytokines to prevent the invasion of oral pathogens. The oral cavity is constantly exposed to a great number of microorganisms. To fight against infection and maintain oral tissue homeostasis, the expression and function of cell surface receptors such as toll-like receptors (TLRs) are essential. TLRs belong to the family of pattern recognition receptors (PRRs) that recognize molecular structures categorized as "pathogen-associated molecular patterns" (PAMPs) present in microorganisms. Binding to TLRs triggers the activation of downstream signaling pathways and stimulates both innate and adaptive immune responses to suppress infection. Epithelial cells also engage distinct innate immune pathways that are implicated in the pathogenesis of oral cancer. The anticancer strategies of innate immunity include the development of an epithelial barrier, direct cytotoxicity, and presentation to various immune cells. Immune cells may have a dual impact by either promoting or suppressing cancer cell growth. Future research should investigate the factors that determine whether epithelial and immune cells promote or inhibit tumor growth. Although the mechanisms underlying this balance are not fully understood, enhancing innate immunity to combat oral infections and cancer holds potential as a strategy for early disease detection and improved treatment outcomes. Additionally, individual variations in host innate immune responses, contributing to oral cancer development, are another aspect of the complexity that requires further research.

Indexed as

Epithelial CellsImmunity, InnateMouth MucosaMouth NeoplasmsAnimalsHumansSignal TransductionToll-Like ReceptorsToll-Like ReceptorsInnate immune responseOral cancer immunologyOral epithelial barrierOral mucosal immunityToll-like receptors (TLRs)

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.